Skip to main content

Advertisement

Log in

Low Intestinal Glutamine Level and Low Glutaminase Activity in Crohn’s Disease: A Rational for Glutamine Supplementation?

  • Original Paper
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Intestinal glutamine utilization is integral to mucosal regeneration. We analyzed the systemic and intestinal glutamine status in Crohn’s disease (CD) and evaluated the therapeutic effect of glutamine supplementation in an animal model of ileitis. In CD, glutamine concentrations were decreased systemically and in noninflamed and inflamed ileal/colonic mucosa. Mucosal glutaminase activities were depressed in the ileum independent of inflammation but were not different from controls in the colon. In experimental ileitis, oral glutamine feeding prevented macroscopic inflammation, enhanced ileal and colonic glutaminase activities above controls, and normalized the intestinal glutathione redox status. However, glutamine supplementation enhanced myeloperoxidase activity along the gastrointestinal tract and potentiated lipid peroxidation in the colon. In conclusion, glutamine metabolism is impaired in CD. In experimental ileitis, glutamine supplementation prevents inflammatory tissue damage. In the colon, however, which does not use glutamine as its principal energy source, immune enhancement of inflammatory cells by glutamine increases oxidative tissue injury.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Wilmore DW (2001) The effect of glutamine supplementation in patients following elective surgery and accidental injury. J Nutr 131:2543S–2549S

    CAS  PubMed  Google Scholar 

  2. Boelens PG, Nijveldt RJ, Houdijk APJ, Meijer S, van Leeuwen PAM (2001) Glutamine alimentation in catabolic states. J Nutr 131:2569S–2577S

    CAS  PubMed  Google Scholar 

  3. Labow BI, Souba WW (2000) Glutamine. World J Surg 24:1503–1513

    Article  CAS  PubMed  Google Scholar 

  4. Souba WW, Klimberg VS, Plumley DA, Salloum RM, Flynn TC, Bland KI, Copeland EM (1990) The role of glutamine in maintaining a healthy gut and supporting the metabolic response to injury and infection. J Surg Res 48:383–391

    Article  CAS  PubMed  Google Scholar 

  5. Wilmore DW, Smith RJ, O’Dwyer ST, Jacobs DO, Ziegler TR, Wang XD (1988) The gut: a central organ after surgical stress. Surgery 104:917–923

    CAS  PubMed  Google Scholar 

  6. Windmueller HG (1982) Glutamine utilization by the small intestine. Adv Enzymol 53:201–237

    CAS  PubMed  Google Scholar 

  7. Windmueller HG, Spaeth AE (1980) Respiratory fuels and nitrogen metabolism in vivo in small intestine of fed rats. J Biol Chem 255:107–112

    CAS  PubMed  Google Scholar 

  8. Coëffier M, Claeyssens S, Hecketsweiler B, Lavoinne A, Ducrotté, Déchelotte P (2003) Enteral glutamine stimulates protein synthesis and decreases ubiquitin mRNA level in human gut mucosa. Am J Physiol 285:G266–G273

    Google Scholar 

  9. Newsholme P, Lima MMR, Procopio J, Pithon-Curi TC, Doi SQ, Bazotte RB, Curi R (2003) Glutamine and glutamate as vital metabolites. Braz J Med Biol Res 36:153–163

    Article  CAS  PubMed  Google Scholar 

  10. Roth E, Oehler R, Manhart N, Exner R, Wessner B, Strasser E, Spittler A (2002) Regulative potential of glutamine: relation to glutathione metabolism. Nutrition 18:217–221

    Article  CAS  PubMed  Google Scholar 

  11. James LA, Lunn PG, Middleton S, Elia M (1998) Distribution of glutaminase and glutamine synthetase activities in the human gastrointestinal tract. Clin Sci (Lond) 94:313–319

    CAS  Google Scholar 

  12. Li J, Langkamp-Henken B, Suzuki K, Stahlgren LH (1994) Glutamine prevents parenteral nutrition-induced increases in intestinal permeability. JPEN J Parenter Enteral Nutr 18:303–307

    CAS  PubMed  Google Scholar 

  13. Platell C, McCauley R, McCulloch R, Hall J (1993) The influence of parenteral glutamine and branched-chain amino acids on total parenteral nutrition-induced atrophy of the gut. JPEN J Parenter Enteral Nutr 17:348–354

    CAS  PubMed  Google Scholar 

  14. Tremel H, Kienle B, Weilemann LS, Stehle P, Fürst P (1994) Glutamine dipeptide-supplemented parenteral nutrition maintains intestinal function in the critically ill. Gastroenterology 107:1595–1601

    CAS  PubMed  Google Scholar 

  15. van der Hulst RW, van Kreel BK, von Meyenfeldt MF, Brummer RJM, Arends JW, Deutz NEP, Soeters PB (1993) Glutamine and the preservation of gut integrity. Lancet 341:1363–1365

    Article  CAS  PubMed  Google Scholar 

  16. Horvath K, Jami M, Hill ID, Papadimitriou JC, Magder LS, Chanasongcram S (1996) Isocaloric glutamine-free diet and the morphology and function of rat small intestine. JPEN J Parenter Enteral Nutr 20:128–134

    CAS  PubMed  Google Scholar 

  17. Inoue YI, Grant JP, Snyder PJ (1993) Effect of glutamine-supplem-ented total parenteral nutrition on recovery of the small intestine after starvation atrophy. JPEN J Parenter Enteral Nutr 17:165–170

    CAS  PubMed  Google Scholar 

  18. Buchman AL (2001) Glutamine: commercially essential or conditionally essential? A critical appraisal of the human data. Am J Clin Nutr 74:25–32

    CAS  PubMed  Google Scholar 

  19. Fox AD, Kripke SA, DePaula J, Berman JM, Settle RG, Rombeau JL (1988) Effect of a glutamine-supplemented enteral diet on methotrexate-induced enterocolitis. JPEN J Parenter Enteral Nutr 12:325–331

    CAS  PubMed  Google Scholar 

  20. Fox AD, De Paula JA, Kripke SA, Palacio JC, Berman JM, Settle RG, Rombeau JL (1988) Glutamine-supplemented elemental diets reduce endotoxemia in a lethal model of enterocolitis. Surg Forum 39:46–47

    CAS  Google Scholar 

  21. Klimberg VS, Souba WW, Dolson DJ, Salloum RM, Hautamaki RD, Plumley DA, Mendenhall WM, Bova FJ, Khan SR, Hackett RL, Bland KI, Copeland EM (1990) Prophylactic glutamine protects the intestinal mucosa from radiation injury. Cancer 66:62–68

    Article  CAS  PubMed  Google Scholar 

  22. Souba WW, Klimberg VS, Hautamaki RD, Mendenhall WH, Bova FC, Howard RJ, Bland KI, Copeland EM (1990) Oral glutamine reduces bacterial translocation following abdominal radiation. J Surg Res 48:1–5

    Article  CAS  PubMed  Google Scholar 

  23. Fujita T, Sakurai K (1995) Efficacy of glutamine-enriched enteral nutrition in an experimental model of mucosal ulcerative colitis. Br J Surg 82:749–751

    CAS  PubMed  Google Scholar 

  24. Kaya E, Gür ES, Özguc H, Bayer A, Tokyay R (1999) L-glutamine enemas attenuate mucosal injury in experimental colitis. Dis Colon Rectum 42:1209–1215

    Article  CAS  PubMed  Google Scholar 

  25. Shinozaki M, Saito H, Muto T (1997) Excess glutamine exacerbates trinitrobenzenesulfonic acid-induced colitis in rats. Dis Colon Rectum 40(Suppl):S59–S63

    Article  CAS  PubMed  Google Scholar 

  26. Neilly PJD, Gardiner KR, Kirk SJ, O’Hare M, Jennings G, Anderson NH, Elia M, Rowlands BJ (1995) Topical glutamine therapy in experimental inflammatory bowel disease. Clin Nutr 14:283–287

    Article  CAS  PubMed  Google Scholar 

  27. Israeli E, Berenshtein E, Wegrower D, Aptekar L, Kohen R, Zajicek G, Goldin E (2004) Prophylactic administration of topical glutamine enhances the capability of the rat colon to resist inflammatory damage. Dig Dis Sci 49:1705–1712

    Article  CAS  PubMed  Google Scholar 

  28. Akobeng AK, Miller V, Thomas AG, Richmond K (2000) Glutamine supplementation and intestinal permeability in Crohn’s disease. JPEN J Parenter Enteral Nutr 24:196

    CAS  PubMed  Google Scholar 

  29. Hond ED, Hiele M, Peeters M, Ghoos Y, Rutgeerts P (1999) Effect of long-term oral glutamine supplements on small intestinal permeability in patients with Crohn’s disease. JPEN J Parenter Enteral Nutr 23:7–11

    Google Scholar 

  30. Akobeng AK, Miller V, Stanton J, Elbadri AM, Thomas AG (2000) Double-blind randomized controlled trial of glutamine-enriched polymeric diet in the treatment of active Crohn’s disease. J Pediatr Gastroenterol Nutr 30:78–84

    Article  CAS  PubMed  Google Scholar 

  31. Yamada T, Deitch E, Specian RD, Perry MA, Sartor RB, Grisham MB (1993) Mechanisms of acute and chronic intestinal inflammation induced by indomethacin. Inflammation 17:641–662

    Article  CAS  PubMed  Google Scholar 

  32. Sido B, Hack V, Hochlehnert A, Lipps H, Herfarth C, Dröge W (1998) Impairment of intestinal glutathione synthesis in patients with inflammatory bowel disease. Gut 42:485–492

    Article  CAS  PubMed  Google Scholar 

  33. Pinkus LM, Windmueller HG (1977) Phosphate-dependent glutaminase of small intestine: localization and role in glutamine metabolism. Arch Biochem Biophys 182:506–517

    Article  CAS  PubMed  Google Scholar 

  34. Habig WH, Pabst MJ, Jakoby WB (1974) Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 249:7130–7139

    CAS  PubMed  Google Scholar 

  35. Seelig GF, Meister A (1985) Glutathione biosynthesis; gamma-glutamylcysteine synthetase from rat kidney. Methods Enzymol 113:379–390

    CAS  PubMed  Google Scholar 

  36. Krawisz JE, Sharon P, Stenson WF (1984) Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Gastroenterology 87:1344–1350

    CAS  PubMed  Google Scholar 

  37. Sido B, Breitkreutz R, Seel C, Herfarth C, Meuer S (2002) Redox processes regulate intestinal lamina propria T lymphocytes. Methods Enzymol 352:232–247

    CAS  PubMed  Google Scholar 

  38. Ohkawa H, Ohishi N, Yagi K (1979) Assay of lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351–358

    Article  CAS  PubMed  Google Scholar 

  39. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265–275

    CAS  PubMed  Google Scholar 

  40. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254

    Article  CAS  PubMed  Google Scholar 

  41. Chapman MAS, Grahn MF, Giamundo P, O’Connell PR, Onwu D, Hutton M, Maudsley J, Norton B, Rogers J, Williams NS (1993) New technique to measure mucosal metabolism and its use to map substrate utilization in the healthy human large bowel. Br J Surg 80:445–449

    CAS  PubMed  Google Scholar 

  42. Souba WW, Herskowitz K, Klimberg VS, Salloum RM, Plumley DA, Flynn TC, Copeland EM (1990) The effects of sepsis and endotoxemia on gut glutamine metabolism. Ann Surg 211:543–550

    Article  CAS  PubMed  Google Scholar 

  43. Reimund JM, Wittersheim C, Dumont S, Muller CD, Kenney JS, Baumann R, Poindron P, Duclos B (1996) Increased production of tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn’s disease. Gut 39:684–689

    CAS  PubMed  Google Scholar 

  44. Austgen TR, Chen MK, Dudrick PS, Copeland EM, Souba WW (1992) Cytokine regulation of intestinal glutamine utilization. Am J Surg 163:174–180

    Article  CAS  PubMed  Google Scholar 

  45. van der Hulst RW, Deutz NEP, von Meyenfedt MF, Elbers JMH, Stockbrügger RW, Soeters PB (1994) Decrease of mucosal glutamine concentration in the nutritionally depleted patient. Clin Nutr 13:228–233

    Article  CAS  PubMed  Google Scholar 

  46. van der Hulst RW, von Meyenfeldt MF, Deutz NEP, Stockbrügger RW, Soeters PB (1996) The effect of glutamine administration on intestinal glutamine content. J Surg Res 61:30–34

    Article  CAS  PubMed  Google Scholar 

  47. van der Hulst RW, von Meyenfeldt MF, Deutz NEP, Soeters PB (1997) Glutamine extraction by the gut is reduced in patients with depleted gastrointestinal cancer. Ann Surg 225:112–121

    Article  CAS  PubMed  Google Scholar 

  48. Salloum RM, Souba WW, Klimberg VS, Plumley DA, Dolson DJ, Bland KI, Copeland EM (1989) Glutamine is superior to glutamate in supporting gut metabolism, stimulating intestinal glutaminase activity, and preventing bacterial translocation. Surg Forum 40:6–8

    Google Scholar 

  49. Kong SE, Hall JC, Cooper D, McCauley RD (2000) Glutamine-enr-iched parenteral nutrition regulates the activity and expression on intestinal glutaminase. Biochim Biophys Acta 1475:67–75

    CAS  PubMed  Google Scholar 

  50. Cao Y, Feng Z, Hoos A, Klimberg VS (1998) Glutamine enhances gut glutathione production. JPEN J Parenter Enteral Nutr 22:224–227

    Article  CAS  PubMed  Google Scholar 

  51. Jensen JC, Schaefer R, Nwokedi E, Bevans DW, Baker ML, Pappas AA, Westbrook KC, Klimberg VS (1994) Prevention of chronic radiation enteropathy by dietary glutamine. Ann Surg Oncol 1:157–163

    Article  CAS  PubMed  Google Scholar 

  52. Martensson J, Jain A, Meister A (1990) Glutathione is required for intestinal function. Proc Natl Acad Sci USA 87:1715–1719

    Article  CAS  PubMed  Google Scholar 

  53. Ishii T, Sugita Y, Bannai S (1987) Regulation of glutathione levels in mouse spleen lymphocytes by transport of cysteine. J Cell Physiol 133:330–336

    Article  CAS  PubMed  Google Scholar 

  54. Newsholme P (2001) Why is L-glutamine metabolism important to cells of the immune system in health, postinjury, surgery or infection? J Nutr 131:2515S–2522S

    CAS  PubMed  Google Scholar 

  55. Arndt H, Kullmann F, Reuss F, Schölmerich J, Palitzsch KD (1999) Glutamine attenuates leukocyte-endothelial cell adhesion in indomethacin-induced intestinal inflammation in the rat. JPEN J Parenter Enteral Nutr 23:12–18

    CAS  PubMed  Google Scholar 

  56. Pithon-Curi TC, Schumacher RI, Freitas JJ, Lagranha C, Newsholme P, Palanch AC, Doi SQ, Curi R (2003) Glutamine delays spontaneous apoptosis in neutrophils. Am J Physiol Cell Physiol 284:C1355–C1361

    CAS  PubMed  Google Scholar 

  57. Furukawa S, Saito H, Inoue T, Matsuda T, Fukatsu K, Han I, Ikeda S, Hidemura A (2000) Supplemental glutamine augments phagocytosis and reactive oxygen intermediate production by neutrophils and monocytes from postoperative patients in vitro. Nutrition 16:323–329

    Article  CAS  PubMed  Google Scholar 

  58. Adjei AA, Morioka T, Ameho CK, Yamauchi K, Kulkarni AD, Al-Mansouri HMSH, Kawajiri A, Yamamoto S (1996) Nucleoside-nucleotide free diet protects rat colonic mucosa from damage induced by trinitrobenzene sulphonic acid. Gut 39:428–433

    CAS  PubMed  Google Scholar 

  59. Foitzik T, Kruschewski M, Kroesen AJ, Hotz HG, Eibl G, Buhr HJ (1999) Does glutamine reduce bacterial translocation? A study in two animal models with impaired gut barrier. Int J Colorectal Dis 14:143–149

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bernd Sido.

Additional information

Supported by grants from the University of Heidelberg (BS) and the German Cancer Research Center (WD; project 072006).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sido, B., Seel, C., Hochlehnert, A. et al. Low Intestinal Glutamine Level and Low Glutaminase Activity in Crohn’s Disease: A Rational for Glutamine Supplementation?. Dig Dis Sci 51, 2170–2179 (2006). https://doi.org/10.1007/s10620-006-9473-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-006-9473-x

Keywords

Navigation